Higher Serum S100B and BDNF Levels Are Correlated with a Lower Pressure-pain Threshold in Fibromyalgia

Overview

Journal Mol Pain

Date 2014 Jul 10

PMID 25005881

Citations 39

Authors

Simone Azevedo Zanette

Jairo Alberto Dussan-Sarria

Andressa Souza

Alicia Deitos

Iraci Lucena Silva Torres

Wolnei Caumo

Affiliations

Soon will be listed here.

Abstract

Background: Fibromyalgia (FM) is conceptualized as a central sensitization (CS) condition, that presents high serum brain-derived neurotrophic factor (BDNF) and neuroglia activation. Although the S100B protein regulates neuroglia functions, it has been traditionally used as a proxy of central nervous system damage. However, neither BDNF nor S100B association with the clinical picture of FM has been elucidated. To explore their association with the pressure-pain threshold (PPT) in FM, we performed a cross-sectional study, including 56 females with confirmed FM aged 18-65 years. Linear regression models were used to adjust for potential confounding factors between serum BDNF, S100B and PPT.

Results: Serum BDNF and S100B were correlated (Spearman's Rho = 0.29). Serum BDNF (log) and S100B (log) were correlated with the PPT (log) (Partial η2 = 0.129, P = 0.012 for the BDNF (log), and Partial η2 = 0.105, P = 0.025 for the S100B (log)). Serum BDNF (log) was inversely associated with PPT (log) (β = -1.01, SE = 0.41), age (β = -0.02, SE = 0.15) and obsessive compulsive disorder (β = -0.36, SE = 0.15), while serum S100B (log) was inversely associated with PPT (log) (β = -1.38, SE = 0.50), only.

Conclusions: Both neuroglia key mediators in the CS process were inversely correlated with the PPT. Serum assessment of BDNF and S100B deserve further study to determine its potential as a proxy for the CS spectrum in FM.

Citing Articles

Epigenetic Landscapes of Pain: DNA Methylation Dynamics in Chronic Pain.

Xiong H, Wyns A, Van Campenhout J, Hendrix J, de Bruyne E, Godderis L Int J Mol Sci. 2024; 25(15).

PMID: 39125894 PMC: 11312850. DOI: 10.3390/ijms25158324.

Characterization of pain-related behaviors in a rat model of acute-to-chronic low back pain: single vs. multi-level disc injury.

Barbe M, Chen F, Loomis R, Harris M, Kim B, Xie K Front Pain Res (Lausanne). 2024; 5:1394017.

PMID: 38770243 PMC: 11102983. DOI: 10.3389/fpain.2024.1394017.

Predictive value of S100B and brain derived neurotrophic factor for radiofrequency treatment of lumbar disc prolapse.

Fathy W, Hussein M, Magdy R, Elmoutaz H, Youssef N, Abd Alla M BMC Anesthesiol. 2024; 24(1):161.

PMID: 38671372 PMC: 11046968. DOI: 10.1186/s12871-024-02527-4.

The Role of the Brain-Derived Neurotrophic Factor in Chronic Pain: Links to Central Sensitization and Neuroinflammation.

Xiong H, Hendrix J, Schabrun S, Wyns A, Van Campenhout J, Nijs J Biomolecules. 2024; 14(1).

PMID: 38254671 PMC: 10813479. DOI: 10.3390/biom14010071.

Brain-derived neurotrophic factor in fibromyalgia: A systematic review and meta-analysis of its role as a potential biomarker.

Behnoush A, Khalaji A, Khanmohammadi S, Alehossein P, Saeedian B, Shobeiri P PLoS One. 2023; 18(12):e0296103.

PMID: 38127937 PMC: 10734974. DOI: 10.1371/journal.pone.0296103.

References

Asmundson G, Norton P, Norton G . Beyond pain: the role of fear and avoidance in chronicity. Clin Psychol Rev. 1999; 19(1):97-119. DOI: 10.1016/s0272-7358(98)00034-8. View

Taves S, Berta T, Chen G, Ji R . Microglia and spinal cord synaptic plasticity in persistent pain. Neural Plast. 2013; 2013:753656. PMC: 3759269. DOI: 10.1155/2013/753656. View

Imbe H, Kimura A, Donishi T, Kaneoke Y . Effects of restraint stress on glial activity in the rostral ventromedial medulla. Neuroscience. 2013; 241:10-21. DOI: 10.1016/j.neuroscience.2013.03.008. View

Castro-Sanchez A, Mataran-Penarrocha G, Lopez-Rodriguez M, Lara-Palomo I, Arendt-Nielsen L, Fernandez-de-Las-Penas C . Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain Med. 2012; 13(12):1639-47. DOI: 10.1111/j.1526-4637.2012.01523.x. View

Perrot S, Vicaut E, Servant D, Ravaud P . Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: The DEFI study (Determination of Epidemiology of FIbromyalgia). BMC Musculoskelet Disord. 2011; 12:224. PMC: 3196738. DOI: 10.1186/1471-2474-12-224. View

Bianchi R, Giambanco I, Donato R . S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol Aging. 2008; 31(4):665-77. DOI: 10.1016/j.neurobiolaging.2008.05.017. View

Wolfe F, Walitt B . Culture, science and the changing nature of fibromyalgia. Nat Rev Rheumatol. 2013; 9(12):751-5. DOI: 10.1038/nrrheum.2013.96. View

Staud R, Vierck C, Cannon R, Mauderli A, Price D . Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 2001; 91(1-2):165-75. DOI: 10.1016/s0304-3959(00)00432-2. View

Giesecke T, Gracely R, Williams D, Geisser M, Petzke F, Clauw D . The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005; 52(5):1577-84. DOI: 10.1002/art.21008. View

10.

Kleindienst A, Schmidt C, Parsch H, Emtmann I, Xu Y, Buchfelder M . The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity. Cardiovasc Psychiatry Neurol. 2010; 2010:801295. PMC: 2910463. DOI: 10.1155/2010/801295. View

11.

Diers M, Yilmaz P, Rance M, Thieme K, Gracely R, Rolko C . Treatment-related changes in brain activation in patients with fibromyalgia syndrome. Exp Brain Res. 2012; 218(4):619-28. DOI: 10.1007/s00221-012-3055-2. View

12.

Sairanen M, Lucas G, Ernfors P, Castren M, Castren E . Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci. 2005; 25(5):1089-94. PMC: 6725966. DOI: 10.1523/JNEUROSCI.3741-04.2005. View

13.

Haas L, Portela L, Bohmer A, Oses J, Lara D . Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res. 2010; 35(5):830-4. DOI: 10.1007/s11064-010-0129-z. View

14.

Latremoliere A, Woolf C . Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10(9):895-926. PMC: 2750819. DOI: 10.1016/j.jpain.2009.06.012. View

15.

Vos P, Jacobs B, Andriessen T, Lamers K, Borm G, Beems T . GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology. 2010; 75(20):1786-93. DOI: 10.1212/WNL.0b013e3181fd62d2. View

16.

Schatzberg A . The relationship of chronic pain and depression. J Clin Psychiatry. 2004; 65 Suppl 12:3-4. View

17.

Donato R, Cannon B, Sorci G, Riuzzi F, Hsu K, Weber D . Functions of S100 proteins. Curr Mol Med. 2012; 13(1):24-57. PMC: 3707951. View

18.

Sarchielli P, Mancini M, Floridi A, Coppola F, Rossi C, Nardi K . Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain. 2007; 8(9):737-45. DOI: 10.1016/j.jpain.2007.05.002. View

19.

Maestu C, Cortes A, Vazquez J, Del Rio D, Gomez-Arguelles J, Del Pozo F . Increased brain responses during subjectively-matched mechanical pain stimulation in fibromyalgia patients as evidenced by MEG. Clin Neurophysiol. 2012; 124(4):752-60. DOI: 10.1016/j.clinph.2012.09.015. View

20.

Fuller-Thomson E, Nimigon-Young J, Brennenstuhl S . Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey. Rheumatol Int. 2011; 32(4):853-62. DOI: 10.1007/s00296-010-1713-x. View